RU2768746C2 - Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы - Google Patents
Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы Download PDFInfo
- Publication number
- RU2768746C2 RU2768746C2 RU2019121694A RU2019121694A RU2768746C2 RU 2768746 C2 RU2768746 C2 RU 2768746C2 RU 2019121694 A RU2019121694 A RU 2019121694A RU 2019121694 A RU2019121694 A RU 2019121694A RU 2768746 C2 RU2768746 C2 RU 2768746C2
- Authority
- RU
- Russia
- Prior art keywords
- ethyl
- tetrahydropyran
- spiro
- oxo
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16203335.1 | 2016-12-12 | ||
| EP16203335 | 2016-12-12 | ||
| PCT/EP2017/082424 WO2018108910A1 (en) | 2016-12-12 | 2017-12-12 | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2019121694A RU2019121694A (ru) | 2021-01-12 |
| RU2019121694A3 RU2019121694A3 (cg-RX-API-DMAC7.html) | 2021-01-21 |
| RU2768746C2 true RU2768746C2 (ru) | 2022-03-24 |
Family
ID=57542834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019121694A RU2768746C2 (ru) | 2016-12-12 | 2017-12-12 | Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11065257B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3551632B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7008073B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110167944B (cg-RX-API-DMAC7.html) |
| ES (1) | ES2981006T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2768746C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018108910A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018286964B2 (en) | 2017-06-20 | 2022-04-14 | UNION therapeutics A/S | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds |
| WO2019115776A1 (en) | 2017-12-15 | 2019-06-20 | Leo Pharma A/S | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors |
| GB202306662D0 (en) | 2023-05-05 | 2023-06-21 | Union Therapeutics As | Dosage regimen |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA005071B1 (ru) * | 2000-01-05 | 2004-10-28 | Уорнер-Ламберт Компани | ЗАМЕЩЕННЫЕ ПИРАЗОЛО[4,3-e]ДИАЗЕПИНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ, И ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ ПРОДУКТОВ |
| WO2007040435A1 (en) * | 2005-10-03 | 2007-04-12 | Astrazeneca Ab | Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease. |
| WO2008060597A2 (en) * | 2006-11-15 | 2008-05-22 | Vertex Pharmaceuticals Incorporated | Compounds useful as protein kinase inhibitors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7423031B2 (en) | 2003-05-01 | 2008-09-09 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| WO2007115232A2 (en) * | 2006-03-30 | 2007-10-11 | Chemocentryx, Inc. | Cxcr4 modulators |
| PL2114951T3 (pl) * | 2007-02-28 | 2014-10-31 | Leo Pharma As | Nowe inhibitory fosfodiesterazy |
| GB0704652D0 (en) | 2007-03-09 | 2007-04-18 | Syngenta Participations Ag | Novel herbicides |
| WO2011003005A1 (en) * | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof |
| CN110088108B (zh) * | 2016-12-12 | 2024-06-14 | 联合疗法公司 | 取代的吡唑并氮杂䓬-4-酮类及其作为磷酸二酯酶抑制剂的用途 |
| ES2874632T3 (es) * | 2016-12-12 | 2021-11-05 | Union Therapeutics As | Pirazoloazepin-8-onas sustituidas y su uso como inhibidores de la fosfodiesterasa |
-
2017
- 2017-12-12 US US16/468,444 patent/US11065257B2/en active Active
- 2017-12-12 JP JP2019531241A patent/JP7008073B2/ja not_active Expired - Fee Related
- 2017-12-12 CN CN201780076412.5A patent/CN110167944B/zh not_active Expired - Fee Related
- 2017-12-12 RU RU2019121694A patent/RU2768746C2/ru active
- 2017-12-12 ES ES17811328T patent/ES2981006T3/es active Active
- 2017-12-12 WO PCT/EP2017/082424 patent/WO2018108910A1/en not_active Ceased
- 2017-12-12 EP EP17811328.8A patent/EP3551632B1/en active Active
-
2021
- 2021-06-10 US US17/303,955 patent/US20220362259A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA005071B1 (ru) * | 2000-01-05 | 2004-10-28 | Уорнер-Ламберт Компани | ЗАМЕЩЕННЫЕ ПИРАЗОЛО[4,3-e]ДИАЗЕПИНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ, И ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ ПРОДУКТОВ |
| WO2007040435A1 (en) * | 2005-10-03 | 2007-04-12 | Astrazeneca Ab | Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease. |
| WO2008060597A2 (en) * | 2006-11-15 | 2008-05-22 | Vertex Pharmaceuticals Incorporated | Compounds useful as protein kinase inhibitors |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110167944B (zh) | 2024-08-23 |
| US11065257B2 (en) | 2021-07-20 |
| WO2018108910A1 (en) | 2018-06-21 |
| RU2019121694A (ru) | 2021-01-12 |
| JP7008073B2 (ja) | 2022-01-25 |
| EP3551632B1 (en) | 2024-06-12 |
| US20220362259A1 (en) | 2022-11-17 |
| CN110167944A (zh) | 2019-08-23 |
| EP3551632C0 (en) | 2024-06-12 |
| JP2020511410A (ja) | 2020-04-16 |
| US20200323869A1 (en) | 2020-10-15 |
| EP3551632A1 (en) | 2019-10-16 |
| ES2981006T3 (es) | 2024-10-04 |
| RU2019121694A3 (cg-RX-API-DMAC7.html) | 2021-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7198820B2 (ja) | 置換アゼチジンジヒドロチエノピリミジンおよびホスホジエステラーゼ阻害剤としてのそれらの使用 | |
| RU2583787C2 (ru) | Гетероциклические соединения бензодиоксола или бензодиоксепина в качестве ингибиторов фосфодиэстераз | |
| EP3724195B1 (en) | Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors | |
| EP3724196B9 (en) | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors | |
| CN111108109A (zh) | 取代的二氢噻吩并嘧啶及其作为磷酸二酯酶抑制剂的用途 | |
| CA2651454A1 (en) | Imidazoazephinone compounds | |
| RU2762279C2 (ru) | Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы | |
| CN104011048B (zh) | 作为磷酸二酯酶抑制剂的[1,2,4]三唑并吡啶类化合物及其应用 | |
| EP3551632B1 (en) | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors | |
| RU2764273C2 (ru) | Замещенные пиразолоазепин-8-оны и их применение в качестве ингибиторов фосфодиэстеразы | |
| RU2817698C2 (ru) | Замещенные дигидротиенопиримидины и их применение в качестве ингибиторов фосфодиэстеразы | |
| HK40041147A (en) | Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors | |
| HK40039957A (en) | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors | |
| HK40039957B (en) | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors | |
| HK40041148A (en) | Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors | |
| HK40041148B (en) | Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HZ9A | Changing address for correspondence with an applicant |